Linking Performance Measures to Treatment Outcomes

将绩效指标与治疗结果联系起来

• 批准号: 6600288
• 负责人: Deborah W. Garnick
• 金额: $ 15.5万
• 依托单位: BRANDEIS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-05-12 至 2005-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6600288
• 关键词: alcoholism /alcohol abuse therapy; behavioral /social science research tag; clinical research; drug abuse therapy; health care service evaluation; health care service utilization; health services research tag; human data; outcomes research; patient care management; substance abuse related disorder

DESCRIPTION (provided by applicant): This application for an R21 Exploratory/Developmental study is submitted in response to two program announcements: PA-01-142, Health Services Research on Alcohol-Related Problems and PA-02-072, Methodology and Measurement in the Behavioral and Social Sciences. The application is to examine the links between established alcohol and other drug (AOD) performance measures and treatment outcomes in a public sector health care system. This project builds on previous work by the proposed research team that helped to develop the Washington Circle Group (WCG) performance measures. The team has tested these measures in commercial managed care plans, in the proposed study, the project team plans to expand the focus to include public sector provision of AOD services. The study will shed light on how to improve accountability for delivery of AOD treatment services in public health care systems. The specific aims of this proposal are to: 1) Use a state database to test the feasibility of a subset of the WCG performance measures for alcohol and other drugs (AOD) in the public sector. We will use data secondary data from the Oklahoma Department of Mental Health and Substance Abuse Service (ODMHSAS), which has the capability of linking its administrative data set to various other state agency data, resulting in a very rich data source. 2) Evaluate the relationship between the adherence to these measures and client outcomes. We will calculate the WCG performance measures and compare the outcomes for clients who adhere to the performance measures and those who do not. 3) Explore with additional states, the data structure of their administrative data and possible links to other agencies in their states. Our goal is to develop a data set rich enough to support testing the WCG performance measures and their relationship to outcomes in states that represent larger and more diverse populations.

描述（由申请人提供）：本R21探索性/开发性研究申请是根据两项计划公告提交的：PA-01-142，酒精相关问题的卫生服务研究和PA-02-072，行为和社会科学的方法和测量。 该应用程序是检查建立酒精和其他药物（AOD）的性能指标和治疗结果在公共部门的医疗保健系统之间的联系。这个项目建立在以前的工作，由拟议的研究小组，帮助制定华盛顿圈集团（WCG）的业绩衡量。该小组已在商业管理医疗计划中测试了这些措施，在拟议的研究中，项目小组计划将重点扩大到包括公共部门提供的AOD服务。这项研究将阐明如何改善公共卫生保健系统提供AOD治疗服务的问责制。这项建议的具体目标是： 1)使用国家数据库来测试WCG绩效指标的一个子集在公共部门的酒精和其他药物（AOD）的可行性。我们将使用来自俄克拉荷马州精神卫生和药物滥用服务部（ODMHSAS）的数据二级数据，该部门能够将其管理数据集与其他各种州机构数据相关联，从而形成非常丰富的数据源。 2)评估遵守这些措施和客户结果之间的关系。我们将计算WCG绩效指标，并比较遵守和不遵守绩效指标的客户的结果。 3)与其他州探讨其行政数据的数据结构以及与其州内其他机构的可能链接。我们的目标是开发一个足够丰富的数据集，以支持在代表更大和更多样化人口的州测试WCG绩效指标及其与结果的关系。